Maria Pia Soto

Maria Pia Soto

Auto-generated profile, based on publicly available information

Maria Pia Soto

Laboratorio de Infecciones Respiratorias Agudas, Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
CMClaudia Machicado
Claudia Machicado
MSMaria Pia Soto
Maria Pia Soto
OTOlga Timoteo
Olga Timoteo
AVAbraham Vaisberg
Abraham Vaisberg
MPMonica Pajuelo
Monica Pajuelo
LMLuis A. Marcos
Luis A. Marcos
Fascioliasis is an infectious parasitic disease distributed globally and caused by the liver flukes Fasciola hepatica or F. gigantica. This neglected tropical disease affects both animals and humans and it represents a latent public health problem due to the significant economic losses related to animal husbandry. For decades, Triclabendazole has been the unique anti-Fasciola drug that can effectively treat this disease. However, triclabendazole resistance in Fascioliasis has been more recently reported around the world, and thus the discovery of novel drugs is an urgent need. The aim of this study was to investigate the fasciocidal properties of 400 compounds contained in the Pathogen Box. The first stage of the screening was carried out by measuring the fasciocidal activity on metacercariae at a concentration of 33 µM of each compound (standard dose). Subsequently the 50% inhibitory concentration (IC50) values of the most active compounds (n=33) were assayed on metacercariae and resulted in 13 compounds with IC50 ≤ 10 µM. The second stage queried these compounds at 33 µM on adult flukes where seven showed high mortality rates > 50%. Four hit compounds were selected based on predicted nontoxic properties and IC50 values obtained on adult worms resulted < 10 µM thus representing the best fasciocidal compounds tested here. Cytotoxicity assay on four types of cell lines demonstrated that three compounds are nontoxic at its most active concentration. In conclusion, three hit compounds identified in this proof-of-concept study are potential candidates in the discovery of new fasciocidal drugs. Further studies are warranted.

1 July 2021 in Heliyon
Verified
Journal Article
Open access
CMClaudia Machicado
Claudia Machicado
MSMaria Pia Soto
Maria Pia Soto
LCLuis Felipe La Chira
Luis Felipe La Chira
JTJoel Torres
Joel Torres
CMCarlos Mendoza
Carlos Mendoza
Luis A. MarcosLuis A. Marcos
Luis A. Marcos
Liver flukes Fasciola hepatica, Opisthorchis viverrini and Clonorchis sinensis are causing agents of liver and hepatobiliary diseases. A remarkable difference between such worms is the fact that O. viverrini and C. sinensis are carcinogenic organisms whereas F. hepatica is not carcinogenic. The release of secretory factors by carcinogenic flukes seems to contribute to cancer development however if some of these target the host cell nuclei is unknown. We investigated the existence of O. viverrini and C. sinensis secretory proteins that target the nucleus of host cells and compared these with the corresponding proteins predicted in F. hepatica. Here we applied an algorithm composed by in silico approaches that screened and analyzed the potential genes predicted from genomes of liver flukes. We found 31 and 22 secretory proteins that target the nucleus of host cells in O. viverrini and C. sinensis, respectively, and that have no homologs in F. hepatica. These polypeptides have enriched the transcription initiation process and nucleic acid binding in O. viverrini and C. sinensis, respectively. In addition, other 11 secretory proteins of O. viverrini and C. sinensis, that target the nucleus of host cells, had F. hepatica homologs, have enriched RNA processing function. In conclusion, O. viverrini and C. sinensis have 31 and 22 genes, respectively, that may be involved in their carcinogenic action through a direct targeting on the host cell nuclei.

30 September 2022 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
EJEduardo Juscamayta-López
Eduardo Juscamayta-López
FVFaviola Valdivia
Faviola Valdivia
MSMaría Pía Soto
María Pía Soto
HHHelen Horna
Helen Horna
BNBrenda Nureña
Brenda Nureña
Objetivo. Desarrollar y evaluar un método de bajo costo basado en celulosa para la purificación rápida y amplificación directa de ADN de Bordetella pertussis de hisopados nasofaríngeos. Materiales y métodos. Se prepararon discos de celulosa y se evaluaron diferentes parámetros (buffers de lisis/lavado, número de discos y elución de ADN). El método se acopló a una amplificación directa por PCR en tiempo real (qPCR) y se es­timó el rendimiento utilizando hisopados nasofaríngeos que fueron positivos (n=100) y negativos (n=50) para ADN B. pertussis por qPCR, comparado con el método basado en columnas de sílice. Se calculó el grado de concordancia, sensibilidad, especificidad, valor predictivo positivo (VPP) y valor predictivo negativo (VPN). Se evaluó la factibilidad del método rápido para ser acoplado a un ensayo colorimétrico de amplificación isotérmica mediada por lazo (LAMP). Resultados. El método rápido con un disco de celulosa y buffer de lisis y lavado conteniendo PVP-40 y Tween 20, respectivamente, mostró una mayor capacidad para purificar ADN amplificable de B. pertussis. El método tuvo una sensibilidad de 89,0% (IC95%, 80,2%-94,9%) y una especificidad de 98,5% (IC95%, 92,1%-100,0%), con un buen grado de concordancia (Kappa=0,867; IC95% 0,788 – 0,946), respecto al método referencial. Los VPP y VPN fueron 98,6% (IC95%, 92,7,2%-100,0%) y 88,2% (IC95%, 78,7%-94,4%), respectivamente. Se evidenció una amplificación exitosa por LAMP, y se obtuvieron resultados comparables con el método por columnas de sílice. Conclusión. El método desarrollado es simple, de bajo costo y libre de equipos para la obtención rápida (60 segundos) de ADN en el punto de atención, y puede ser implementado en diversas técnicas moleculares orientados al diagnóstico oportuno y al estudio epidemiológico de tos ferina